Activation of EGF receptor family members suppresses the cytotoxic effects of tumor necrosis factor-α

Cancer Immunology Immunotherapy

Volumn 47, Issue 3, 1998, Pages 167-175

  Hoffmann, Michael ^a,b   Schmidt, Mathias ^a   Wels, Winfried ^a  

^a TUMOR BIOLOGY CENTER   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

EGF receptor; ErbB2; Receptor tyrosine kinase; Recombinant antibody; TNF

Indexed keywords

ANTIBODY; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL SURVIVAL; CYTOTOXICITY; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; UTERINE CERVIX CARCINOMA;

ANIMALS; BREAST NEOPLASMS; CARCINOMA; COCULTURE TECHNIQUES; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN FRAGMENTS; MICE; NF-KAPPA B; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031740997     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050517     Document Type: Article

References (33)

1. Aggarwal BB, Totpal K, Ali-Osman F, Budde RJ, Pocsik E (1994) pp60v-src kinase overexpression leads to cellular resistance to the antiproliferative effects of tumor necrosis factor. FEBS Lett 345:219
2. Baker S, Reddy EP (1996) Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1
3. Bäuerle P, Henkel T (1994) Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141
4. Becker JC, Varki N, Gillies SD, Furukawa K, Reisfeld RA (1996) An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response. Proc Natl Acad Sci USA 93:7826
5. Carswell FA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666
6. Donato NJ, Van DH, Hung MC, Rosenblum MG (1993) Epidermal growth factor receptor expression and function control cytotoxic responsiveness to tumor necrosis factor in ME-180 squamous carcinoma cells. Cell Growth Differ 4:411
7. Eck MJ, Sprang SR (1989) The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding. J Biol Chem 264:17595
8. Ennis BW, Valverius EM, Bates SE, Lippman ME, Bellot F, Kris R, Schlessinger J, Masui H, Goldenberg A, Mendelsohn J, Dickson RB (1989) Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells. Mol Endocrinol 3:1830
9. Fong CJ, Sherwood ER, Mendelsohn J, Lee C, Kozlowski JM (1992) Epidermal growth factor receptor monoclonal antibody inhibits constitutive receptor phosphorylation, reduces autonomous growth, and sensitizes androgen-independent prostalic carcinoma cells to tumor necrosis factor alpha. Cancer Res 52:5887
10. Grell M, Scheurich P, Meager A, Pfizenmaier K (1993) TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res 12:143
11. Harwerth IM, Wels W, Schlegel J, Müller M, Hynes NE (1993) Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth. Br J Cancer 68:1140
12. Hoogenboom HR, Raus JC, Volckaert G (1991) Targeting of tumor necrosis factor to tumor cells: secretion by myeloma cells of a genetically engineered antibody-tumor necrosis factor hybrid molecule. Biochim Biophys Acta 1096:345
13. Hori K, Mihich E, Ehrke MJ (1989) Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages. Cancer Res 49:2606
14. Hudziak RM, Lewis GD, Shalaby MR, Eessalu TE, Aggarwal BB, Ullrich A, Shepard HM (1988) Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells. Proc Natl Acad Sci USA 85:5102
15. Hudziak RM, Lewis GD, Winget M, Fendly BM, Shepard HM. Ullrich A (1989) p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol Cell Biol 9:1165
16. Hudziak RM, Lewis GD, Holmes WE, Ullrich A, Shepard HM (1990) Selection for transformation and met protooncogene amplification in NIH 3T3 libroblasts using tumor necrosis factor alpha. Cell Growth Differ 1:129
17. Hwu P, Rosenberg SA (1993) Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with TNF-alpha cDNA for the gene therapy of cancer in humans. J Immunol 150:4104
18. Jeschke M, Weis W, Dengler W, Imber R, Stöcklin E, Groner B (1995) Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins. Int J Cancer 60:730
19. Koshita Y, Lu Y, Fujii S, Neda H, Matsuyama T, Satoh Y, Itoh Y, Takahashi M, Kato J, Sakamaki S, Watanabe N, Kohgo Y, Niitsu Y (1995) Efficacy of TNF-alpha gene-transduced tumor cells in treatment of established in vivo tumor. Int J Cancer 63:130
20. Moritz D, Wels W, Mattern J, Groner B (1994) Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells. Proc Natl Acad Sci USA 91:4318
21. Pahl HL, Baeuerle PA (1995) A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-κ B. EMBO J 14:2580
22. Proba K, Ge L, Plückthun A (1995) Functional antibody single-chain fragments from the cytoplasm of Escherichia coli: influence of thioredoxin reductase (TrxB). Gene 159:203
23. Reisfeld RA, Gillies SD, Mendelsohn J, Varki NM, Becker JC (1996) Involvement of B lymphocytes in the growth inhibition of human pulmonary melanoma metastases in athymic nu nu mice by an antibody-lymphotoxin fusion protein. Cancer Res 56:1707
24. Y antigen-expressing human cancer cells. Clin Cancer Res 2:1523
25. Scheurich P, Thoma B, Ucer U, Pfizenmaier K (1987) Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J Immunol 138:1786
26. Schmidt M, Vakalopoulou E, Schneider DW, Wels W (1997) Construction and functional characterisation of scFv(14E1)-ETA - a novel, highly potent antibody-toxin specific for the EGF receptor. Br J Cancer 75:1575
27. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL, Carraway KL (1994) Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269:14661
28. Sugarman B, Shepard HM (1985) Recombinant tumor necrosis factor alpha: effects on proliferation of normal and transformed cells in vitro. Science 230:943
29. Vassalli P (1992) The pathophysiology of tumor necrosis factor. Annu Rev Immunol 10:411
30. Wang AM, Creasey AA, Ladner MB, Lin LS, Strickler J, Van Arsdell JN, Yamamoto R, Mark DF (1985) Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 228:149
31. Weber E, Lehmann HP, Beck-Sickinger AG, Wawrzynczak EJ, Waibel R, Folkers G, Stahel RA (1993) Antibodies to the protein core of the small cell lung cancer workshop antigen cluster-w4 and to the leucocyte workshop antigen CD24 recognize the same short protein sequence leucine-alanine-proline. Clin Exp Immunol 93:279
32. Weis W, Beerli R, Hellmann P, Schmidt M, Marte BM, Kornilova ES, Hekele A, Mendelsohn J, Groner B, Hynes NE (1995) EGF receptor and p185erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins. Int J Cancer 60:137
33. Yang J, Moyana T, Xiang J (1995) A genetically engineered single-chain FV TNF molecule possesses the anti-tumor immunoreactivity of FV as well as the cytotoxic activity of tumor necrosis factor. Mol Immunol 32:873